AAAAAA
Results:
1-12
|
Results: 12
Authors:
Maruyama, M
Kuribayashi, N
Kawabata, K
Wettlaufer, JS
Citation: M. Maruyama et al., Shocks and curvature dynamics: A test of global kinetic faceting in crystals, PHYS REV L, 85(12), 2000, pp. 2545-2548
Authors:
Maruyama, M
Kawabata, K
Kuribayashi, N
Citation: M. Maruyama et al., Crystal morphologies and melting curves of CCl4 at pressures up to 330 MPa, J CRYST GR, 220(1-2), 2000, pp. 161-165
Authors:
Harada, N
Hata, N
Matsuno, F
Sonoki, T
Kuribayashi, N
Matsuzaki, H
Mitsuya, H
Citation: N. Harada et al., Absence of Kaposi's sarcoma-associated herpesvirus (KSHV) in bone marrow cells from Japanese myeloma patients, LEUKEMIA, 13(9), 1999, pp. 1465-1466
Authors:
Sonoki, T
Matsuzaki, H
Nagasaki, A
Hata, H
Yoshida, M
Matsuoka, M
Kuribayashi, N
Kimura, T
Harada, N
Takatsuki, K
Mitsuya, H
Mori, M
Citation: T. Sonoki et al., Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis byNOS inhibitor, LEUKEMIA, 13(5), 1999, pp. 713-718
Authors:
Iida, M
Doi, H
Asamoto, S
Sugiyama, H
Sakagami, H
Kuribayashi, N
Takeda, M
Okamura, Y
Matsumoto, K
Citation: M. Iida et al., Effect of glutathione-modulating compounds on platinum compounds-induced cytotoxicity in human glioma cell lines, ANTICANC R, 19(6B), 1999, pp. 5383-5384
Authors:
Iida, M
Doi, H
Asamoto, S
Sugiyama, H
Sakagami, H
Shioda, S
Kuribayashi, N
Takeda, M
Okamura, Y
Matsumoto, K
Citation: M. Iida et al., Establishment and characterization of human immature teratoma cell line (TES-1), ANTICANC R, 19(3A), 1999, pp. 1933-1939
Authors:
Iida, M
Doi, H
Asamoto, S
Sugiyama, H
Kuribayashi, N
Sakagami, H
Takeda, M
Matsumoto, K
Citation: M. Iida et al., Endonuclease activity and hydrogen peroxide-induced cytotoxicity in human glioblastoma and glioma cell lines, ANTICANC R, 19(2A), 1999, pp. 1235-1240
Authors:
Sonoki, T
Hata, H
Kuribayashi, N
Yoshida, M
Harada, N
Nagasaki, A
Kimura, T
Matsuno, F
Mitsuya, H
Matsuzaki, H
Citation: T. Sonoki et al., Expression of PRAD1 cyclin D1 in plasma cell malignancy: incidence and prognostic aspects, BR J HAEM, 104(3), 1999, pp. 614-617
Authors:
Sonoki, T
Matsuzaki, H
Satterwhite, E
Nakazawa, N
Hata, H
Tucker, PW
Taniwaki, M
Kuribayashi, N
Harada, N
Matsuno, F
Mitsuya, H
Citation: T. Sonoki et al., A plasma cell leukemia patient showing bialleic 14q translocations: t(2;14) and t(11;14), ACT HAEMAT, 101(4), 1999, pp. 197-201
Authors:
Kuribayashi, N
Hata, H
Yoshida, M
Sonoki, T
Nagasaki, A
Kimura, T
Harada, N
Matsuzaki, H
Citation: N. Kuribayashi et al., Establishment and characterization of a CD95 (Fas/Apo-1)-negative myeloma cell line, ACT HAEMAT, 101(3), 1999, pp. 113-118
Authors:
Kuribayashi, N
Hata, H
Matsuzaki, H
Yoshida, M
Sonoki, T
Nagasaki, A
Kimura, T
Harada, N
Takatsuki, K
Citation: N. Kuribayashi et al., Establishment of a monoclonal antibody to human myeloma cell: relation to chemotherapy and extramedullar infiltration, MED ONCOL, 15(4), 1998, pp. 248-254
Authors:
Sonoki, T
Nakazawa, N
Hata, H
Taniwaki, M
Nagasaki, A
Seto, M
Yoshida, M
Kuribayashi, N
Kimura, T
Harada, N
Mitsuya, H
Matsuzaki, H
Citation: T. Sonoki et al., Amplification and overexpression of the PRAD1 Cyclin D1 gene in a multiplemyeloma cell line, INT J HEMAT, 68(4), 1998, pp. 459-461
Risultati:
1-12
|